Helicobacter pylori eradication for hepatic encephalopathy treatment: The ideal study is still lacking

Journal of Clinical Gastroenterology

Volumn 49, Issue 1, 2015, Pages 88-89

  Zullo, Angelo ^a   Ridola, Lorenzo ^a   De Francesco, Vincenzo ^b   Hassan, Cesare ^a  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b Riuniti Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; NITROGEN; UREASE;

AMMONIA BLOOD LEVEL; BACTERIAL CLEARANCE; ENZYME ACTIVITY; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; COMPLICATION; HELICOBACTER INFECTION; HYPERAMMONEMIA;

HELICOBACTER INFECTIONS; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERAMMONEMIA;

EID: 84929630583     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000139     Document Type: Letter

References (5)

1. Schulz C, Schutte K, Malfertheiner P. Does H. pylori eradication therapy benefit patients with hepatic encephalopathy? Systematic review. J Clin Gastroenteorol. 2014;48:491-499.
2. Zullo A, Hassan C, Morini S. Hepatic encephalopathy and Helicobacter pylori. A critical reappraisal. J Clin Gastroenterol. 2003;37:164-168.
3. Chen SJ, Wang LJ, Zhu Q, et al. Effect of H pylori infection and its eradication on hyperammonemia and hepatic encephalopathy in cirrhotic patients. World J Gastroenterol. 2008;14:1914-1918.
4. Rinaldi V, Zullo A, Diana F, et al. Helicobacter pylori, hyperammonemia, and hepatic encephalopathy: is there a correlation? Am J Gastroenterol. 1997;92:723-724.
5. Zullo A, Rinaldi V, Hassan C, et al. Helicobacter pylori and plasma ammonia levels in cirrhotics: role of urease inhibition by acetohydroxamic acid. Ital J Gastroenterol Hepatol. 1998;30:405-440.